OncoDetect

breast cancer detection, immunosuppression and renal transplantation aids

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Glenelg, MD, USA
  • Currency USD
  • Founded July 2004
  • Website WWW.ONCODETECT.COM

Company Summary

Mission: OncoDetect Inc. is a Bio-pharmaceutical company dedicated to extending and enhancing the lives of cancer and transplant recipients specifically to prevent organ transplant rejection, cancer progression and atherosclerosis·

Team

  • ASHWANI KUMAR KHANNA
    PRESIDENT/CSO

    PhD IN IMMUNOLOGY WITH VAST EXPERIENCE IN PRE-CLINICAL, CLINICAL AND EXPERIMENTAL RESEARCH IN THE AREAS CARDIOVASCULAR, RENAL AND CANCER RELATED DISEASES. EMPHASIS ON THERAPEUTICS AND DIAGNOSTIC ASSAYS.
    DEVELOPING RECOMBINANT p21 PROTEIN AS A POTENTIAL ANTIREJECTION, ANTI-HIV AND ANTI-ATHEROCLEROSIS THERAPEUTIC AGENT
    MOLECULAR DIAGNOSTIC ASSAY FOR BREAST CANCER
    ANIMAL MODELS OF TRANSPLANTATION, HEART FAILURE AND ATHEROSCLEROSIS

  • Ashwani Khanna

Advisors

  • 0
    Lawyer
    Unconfirmed
    0
    Accountant
    Unconfirmed

Previous Investors

  • 0
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free